美国社区老年人处方药数量与适宜性趋势:2011-2020
BACKGROUND: Contemporary data on the quantity and quality of medication use among older adults are lacking. This study examined recent trends in the number and appropriateness of prescription medication use among older adults in the United States.…
要点
- PIM使用从17.0%降至14.7%,无实质变化。
- 心衰患者ACEI/ARBs联合β受体阻滞剂使用仅44.3%(2017-2020),蛋白尿患者ACEI/ARBs使用54.0%。
核心结论
- 美国老年人用药负担仍高,近十年用药适宜性未改善。
主要发现
- PIM使用从17.0%降至14.7%,无实质变化。
- 心衰患者ACEI/ARBs联合β受体阻滞剂使用率2017-2020年为44.3%,蛋白尿患者ACEI/ARBs使用率为54.0%,均无改善。
- 多重用药、高龄、女性及较低社会经济地位通常与更多PIM使用和更少推荐药物使用相关。
关键数值与推荐
- 多重用药定义为≥5种处方药。
- PIM为潜在不适当用药。
- 推荐药物包括心衰患者使用ACEI/ARBs联合β受体阻滞剂,蛋白尿患者使用ACEI/ARBs。
临床怎么用
- 老年医学科医生应关注社区老年人的多重用药和PIM问题,尤其对高龄、女性及低社会经济地位者加强用药审核。
- 对心衰和蛋白尿患者,应评估并优化指南推荐药物的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contemporary data on the quantity and quality of medication use among older adults are lacking. This study examined recent trends in the number and appropriateness of prescription medication use among older adults in the United States. METHODS: Data from the National Health and Nutrition Examination Survey (NHANES) between 2011 and March 2020 were used, and 6 336 adult participants aged 65 and older were included. We examined the number of prescription medication, prevalence of polypharmacy (≥5 prescription drugs), use of potentially inappropriate medication (PIM), and use of recommended medications (angiotensin-converting enzyme inhibitor [ACEI]/angiotensin receptor blockers [ARBs] plus beta-blockers among patients with heart failure and ACEI/ARBs among patients with albuminuria). RESULTS: There has been a slight increase in the prevalence of polypharmacy (39.3% in 2011-2012 to 43.8% in 2017-2020, p for trend = .32). Antihypertensive, antihyperlipidemic, antidiabetic medications, and antidepressants are the most commonly used medications. There was no substantial change in the use of PIM (17.0% to 14.7%). Less than 50% of older adults with heart failure received ACEI/ARBs plus beta-blockers (44.3% in 2017-2020) and approximately 50% of patients with albuminuria received ACEI/ARBs (54.0% in 2017-2020), with no improvement over the study period. Polypharmacy, older age, female, and lower socioeconomic status were generally associated with greater use of PIM but lower use of recommended medications. CONCLUSIONS: The medication burden remained high among older adults in the United States and the appropriate utilization of medications did not improve in the recent decade. Our results underscore the need for greater attentions and interventions to the quality of medication use among older adults.
引用
- Pan S, Li S, Jiang S, et al. Trends in Number and Appropriateness of Prescription Medication Utilization Among Community-Dwelling Older Adults in the United States: 2011-2020. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38644631. doi:10.1093/gerona/glae108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。